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Abstract: This study examined the effects of separate and combined applications of 3-methylcholanthrene, a polycyclic aromatic
hydrocarbon and potent carcinogenic agent, and butylated hydroxytoluene, the antioxidant food additive, on the glycogen levels of
liver, muscle, testis, and tumor tissues in rats. Adult male Wistar albino rats weighing 100–110 g at 8 weeks of age were used in this
study. This study consisted of a control group (n = 9) and 3 different experiment groups in which rats were chronically treated with
3-methylcholanthrene (n = 9) or butylated hydroxytoluene (n = 11) or a combination of these agents (n = 14). Rats were intraperitoneally
injected with a 200 mg kg−1 dose of butylated hydroxytoluene and a 40 mg kg–1 dose of 3-methylcholanthrene. At the end of the 26-week
experimental period, tissues of rats killed via cervical dislocation were placed in 10% trichloroacetic acid for glycogen determination.
Our results showed that the administration of 3-methylcholanthrene, butylated hydroxytoluene, and 3-methylcholanthrene + butylated
hydroxytoluene caused statistically significant changes in the glycogen levels of liver, muscle, and testis tissues, and glycogen was stored
in tumor tissue.
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1. Introduction
3-Methylcholanthrene (MCA) is a polycyclic aromatic
hydrocarbon (PAH) common in polluted urban air and
is a potent carcinogenic agent often used in experimental
cancer studies. For many years, butylated hydroxytoluene
(BHT) has been used as an antioxidant to preserve and
stabilize the freshness, nutritive value, flavor, and color of
foods for human consumption and animal feed products.
Some studies claim these agents cause cancers in the
human liver, lungs, colon, breast, stomach, and urinary
tract (1–3).
PAHs, found in cigarette smoke, charbroiled foods,
and polluted air, are known potent carcinogens that travel
through the placenta to directly stimulate cytochrome P450
enzymes. The most common sources for PAH exposures
are found in heating systems and vehicle motors, and
are the result of the inadequate combustion of solid and
fuel oils. These sources are regarded as the biggest factors
responsible for air pollution (1,2,4). It is thought that 10%
* Correspondence: fikriyepolat@gmail.com

of cancer phenomena related to the respiratory system are
the result of air pollution. Additionally, there is a report
of increased leukemia incidence in some populations
that are exposed to these kinds of substances (5).
Synthetic phenolic antioxidants are added to foods
to retard the auto-oxidation of lipids. BHT, a major
antioxidant, is widely used in foods all over the world
(6,7). It has played a role as a typical promoting agent
for tumorigenesis in biological systems (8). Even though
BHT is not genotoxic or carcinogenic, it may regulate
tumor formation in mouse lung tumorigenesis in
a 2-staged carcinogenesis. Formation of lung tumors
can be either prevented or enhanced by BHT in mice,
depending on the strains and ages of the test subjects.
Following exposure to a single dose of a carcinogen,
BHT treatment with a repeated weekly dose is necessary
to achieve tumor promotion (9,10).
The increase in blood glucose level also elevates the
risk of cancer. Especially in women, (chronic) high blood
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glucose level is known to play an important role in the
development of certain cancer types. Under the age of
49 bad eating habits increase the risk of pancreas, skin,
uterus, and bladder cancers. Glycogen, the storage form
of blood glucose, has an important role especially in liver
and muscle tissues. In various types of cancers, significant
changes in the activity of glycogen synthase have been
reported (11).
The purpose of this study is to contribute to cancer
research by examining the effects of separate and combined
applications of MCA and BHT on the glycogen levels of
the liver, testis, muscle, and tumor tissues of rats. This
research contributes to the understanding of the effects of
BHT on MCA.
2. Materials and methods
2.1. Animals
Fifty nontransgenic adult male rats (Wistar albino strain),
weighing 100 to 110 g, were received at 8 weeks of age and
allowed 1 week for adjustment to their new environment.
The rats were kept in optimal laboratory conditions, fed
with standard rat food, and given tap water ad libitum.
They were randomized into 1 control and 3 experimental
agent administration groups. The rats were first injected
with individual agents, and then together in various dose
combinations. After 26 weeks of injection, the control and
experimental group rats were killed by cervical dislocation.
Liver, muscle, and testis tissues were removed from all
groups, except soft tissue tumors originating in the muscle
at the point of injection in rats receiving MCA. All
procedures on animals were carried out in accordance
with the guidelines of the Animal Ethics Committee of
Cumhuriyet University School of Medicine.
2.2. Experimental design
The rats were exposed to potential carcinogens of MCA
(as a cancer initiator) and BHT (as a progressive agent)
in tissue tumorigenesis in the rat model. MCA (AldrichChem) and BHT (Sigma–B1378) were dissolved in corn
oil. In the chronic MCA and BHT groups, rats were injected
every week with either 40 mg/kg of MCA or 200 mg/kg
of BHT, and the treatments were repeated for 6 weeks. In
the other experiment group (MCA + BHT), following a
single dose of MCA (40 mg/kg), rats were treated with 200
mg/kg of BHT injections for 6 consecutive weeks. Rats in
the control group (n = 9) only received weekly corn oil
injections for 6 weeks. Following their last treatments, 26
weeks later, rats were sacrificed by cervical dislocation and
their tissues were surgically removed. In the chronic MCA
group, we observed the development of soft tissue tumors
in the inguinal regions of 5 rats. The tumors were collected
and they were evaluated as a separate group for glycogen
level assessment.

34

The tissues of the liver (500 mg), muscle (1000 mg),
and testis were quickly harvested and perfused in 10%
trichloroacetic acid. Until the homogenization procedure
was performed, the tissues were stored at +4 °C. Tissues
were homogenized in trichloroacetic acid (1/3 mass/
volume) at 15,000 rpm for 5 min for liver and testis and
15 min for muscle in a tissue homogenizer (Teflon Glass
Homogenizer, B. Braun). Thereafter, homogenates were
centrifuged at 1400 × g for 15 min as described by Roe et al.
(12) and designated according to Carroll et al. (13). In this
study, Beckman–Model spectrophotometry was used.
Calculation
DU
volume of extract
# 100 # 0.9 =
DS # 0.1 #
g of tissue
mg of glycogen per 100 g of tissue
DU: optical density of the unknown,
DS: optical density of the standard
0.1 = mg of glucose in 2 mL of standard solution
0.9 = factor for converting glucose value to glycogen
value
Analysis of variance was used to evaluate the data and
any difference between the average values higher than F
value at a 0.05 significance level was deemed significant (14).
3. Results
During the 26-week period, 6 rats in the chronic MCA
treated group, 1 rat in the chronic BHT treated group, and
1 rat in the MCA + BHT treated group died. Evaluation
of glycogen levels was performed on 9, 11, and 14 rats
in the chronic MCA, chronic BHT, and MCA + BHT
groups, respectively (Table). Tumoral developments were
observed in 5 rats in the chronic MCA injected group.
Those subcutaneous malignant mesenchymal tumors were
4 × 4 cm in diameter and localized at the injection sites.
Fusiform cell proliferation and multinuclear tumoral giant
cells were also detected at the injection site of the chronic
MCA treated animals after histopathologic examination
(Figure 1). Immunohistochemically, desmin and vimentin
were stained positively in those soft, malign tumoral tissue
cells (15).
Glycogen values in rats’ livers administered MCA were
observed to be lower than in control animals, and the
difference was statistically significant (Figure 2). The liver
tissue glycogen level in BHT treated animals, compared
with the control group, was approximately 4 times higher
(Figure 3). Although the hepatic glycogen level in the
MCA + BHT treated group was higher than in the control
group (~1.76 times), this level was lower in the BHT
treated group (Figure 3). In the MCA, BHT, and MCA +
BHT treated groups, differences in hepatic glycogen levels
were found to be significant at the 0.05 probability level
(Table).
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Table. Effects of MCA, BHT, and MCA + BHT application on the glycogen levels (%) of liver, muscle, testis, and tumor tissues.
Control
(n = 9)

MCA
(n = 9)

BHT
(n = 11)

MCA + BHT
(n = 14)

Liver

256.3 ± 4.1 *

22.26 ± 0.36 †

1020.7 ± 100.56 ‡

452.91 ± 3.2 ©

Muscle

22.62 ± 0.35 *

5.85 ± 0.90 †

131.13 ± 4.32 ‡

11.24 ± 0.22 ©

Testis

2.68 ± 0.22 *

1.51 ± 1.82 †

1.39 ± 0.14 ‡

0.51 ± 0.05 ©

Tumor tissues
*

5.93 ± 0.07 †

Data shown with the same letter in each group in the horizontal axis are not different from each other at a 0.05 probability level
(*, †, ‡, ©).

Glycogen % (mg/g)

30
25

Control

20

MCA

15
10
5
0

Liver

Muscle

Testis

Mass

Figure 2. Comparison of glycogen levels (%) in liver, testis,
muscle and tumor tissues among MCA applied in rats. (Control
liver glycogen level is given as ×101).

1200
Control

Figure 1. Malign soft tissue tumor with atypical fusiform cells,
giant tumoral cells (H & E 25) (Polat et al. (13)).

In the MCA treated group, the apparent decrease in
the glycogen level in the muscle tissue was found to be
significant at a 0.05 probability level (Figure 2). When
the glycogen values obtained after BHT application were
compared with both the MCA group and the control
group, a considerable increase was observed in the BHT
group. This increase was 5.8 times more than the control
group, and 22.4 times more than the MCA group (Table).
When compared to the control group, this difference

Glycogen % (mg/g)

1000

BHT

800

MCA+BHT

600
400
200
0

Liver

Muscle

Figure 3. Comparison of glycogen levels (%) in liver and muscle
tissues among BHT and MCA + BHT applied in rats.

in the glycogen level was found to be significant at a
0.05 probability level (Figure 2). Even though there was
an increase in the muscle glycogen level of the MCA
+ BHT treated group, the statistical comparison to the
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MCA treated group did not show any significant change.
Conversely, the glycogen level of the MCA + BHT treated
animals was found to be 91.43% lower than that of the
BHT treated group (P < 0.05).
Another important result of this study was that the
glycogen level induced with BHT alone, compared to the
value induced with MCA alone, was significantly higher
in both liver and muscle tissues; however, administration
of MCA + BHT combination, comparing with BHT alone,
decreased the glycogen level in both liver and muscle
tissues (Table).
The lowest glycogen level percentage in testis tissue was
0.51 ± 0.05 in the MCA + BHT treated group. Comparing
the MCA + BHT treated group with the control, MCA, and
BHT treated groups, the glycogen level was significantly
reduced at 0.05 probability level. When MCA and BHT
were administered separately, they showed reductions
in glycogen levels, when compared to the control group.
These reductions were found to be significant at a 0.05
probability level (Figures 2, 3; Table).
The glycogen level obtained from the tumor tissues was
almost the same as the glycogen level obtained from the
muscle tissue in the MCA group. There was no difference
in glycogen level between these tissues; however, there was
a decrease in the muscle tissue of the control group (Table;
Figure 2).
4. Discussion
In this study, MCA was used as a cancer initiator and
BHT was used as a tumor-promoting agent. BHT has a
significant role as a tumor-promoting agent even though
it is commonly known for its use as a food antioxidant. In
a previous study, Polat et al. (15) studied carcinogenesis
with a similar approach and subsequently in this study we
would like to evaluate the changes in the glycogen levels
in muscle, liver, testis, and tumor tissues. In most of the
carcinogenesis studies in which rats and mice have been
used as subjects, initial tumor development was induced
with the administration of a single dose of carcinogenic
agents. Following tumor induction, the growth of the
tumors was promoted by the chronic administration
of various agents (16–20). In this study, we intended to
generate lung cancer especially in MCA + BHT treated
rats. In other experiment groups, we planned to evaluate
the individual effects of the chronic administration of
the chemical agents. We were unable to generate lung
cancer in the MCA + BHT administered rats. However,
the chronic administration of the MCA induced soft tissue
tumors in the inguinal region of 5 rats. Twenty-six weeks
after the completion of the injections, animal deaths in
our experiment groups prompted us to discontinue the
experiments.
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Our literature search for the chemical agents used in
this study and the levels of glycogen and various other
biochemical parameters revealed no study performed
within the last 10 years.
It was observed that the reductions in glycogen levels
were remarkable in the liver, muscle, and testis of the MCA
treated groups (P < 0.05). One reason for these reductions
may be the fact that the tumoral cells, which result from
applications of MCA, utilize glucose. These tumoral cells
using glucose do not break down the molecule to CO2 or
water (hydrolysis), and they produce lactic acid. In other
words, they are fermented. Thus, cancer cells need energy.
They provide this energy need by using more glucose. The
glucose requirements of tumoral cells are 20 times more
than the needs of normal cells. Consequently, the glycogen
levels in tissues decrease as a result of the increasing
glucose need and occurring anorexia. In the meantime,
lactic acid levels also increase. Increased amounts of lactic
acid cause pain. In a study conducted on Lewis-Wistar rats,
Shearer et al. (21) reported an increase in gluconeogenesis
rates in rats carrying tumors and found that the increase
in the oxidation of CO2 of pyruvate and the conversion
of this molecule into lactic acid and glucose were related
to the increased clearance of pyruvate and uptake. The
findings from Shearer et al. (21), and our findings of
the occurrence of soft-tissue tumors and the marked
reductions in glycogen levels in the MCA treated group, all
demonstrate that increased glucose needs in tumor tissues
and anaerobic respiration are met by producing lactic
acid. Doi et al. (22) subcutaneously administered MCA to
F344 rats and histochemically examined glycogen levels in
the liver. As glycogen stores in the liver cells of rats with
tumors were significantly reduced, compared with the
control group, the researchers concluded that glucose is
expended, cyclically.
Another reason for glycogen-level reductions may
be an increase in activities of enzymes taking part in
the glycogenolysis metabolism. Kleeberg et al. (23)
administered doses of 1, 10, and 100 mg/kg1 MCA to 7-dayold rats and examined aryl hydrocarbon (benzo[a]pyrene)
hyroxylase (AHH), succinate dehydrogenase, and glucose6-phosphatase enzyme activities in the liver and kidney.
They found that AHH activity increased, depending on the
dose. However, they reported that they did not find any
changes in other biochemical parameters, nor did their
investigations using light and electron microscopes show
morphological changes in liver cells of rats treated with the
highest MCA dose.
Safer and Al-Nughamish (24) fed Sprague-Dawley
rats antioxidant BHT, a food additive, for 6-, 12-, 18-,
and 24-week periods in different concentrations and then
compared the results against the control group. They
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Control

2.5
Glycogen % (mg/g)

reported a significant increase in liver weight. The electron
microscopic study showed an increase in lipid drops, as
well as abnormalities in hepatocytes, but a reduction in
glycogen level. Contrary to the study conducted by Safer
and Al-Nughamish (24), our study of Wistar albino rats
given 200 mg/kg1 dose of BHT per week determined
significant increases in the glycogen levels in the liver.
In the experimental design described by Siman
and Eriksson (25), 1 group of female rats was fed BHT
containing vitamin E and 1 group of female rats was given
only BHT for 4 weeks. An increase in the liver weights
of rats treated with just BHT was observed. It was also
determined that BHT metabolized with cytochrome P450
system in the liver and transformed into pro-oxidative
compounds.
Wong and Rao (26), in a study on female rats fed a
diet of BHT for 5 weeks, showed hepatosplenomegaly,
a reduction in body weight, a significant inhibition in
glucose-6-phosphotase activity, hepatic microsomal
protein and cytochrome P-450 induction, and an increase
in cholesterol levels.
Takahashi and Hiraga (27) studied hepatic lipids in
male Sprague-Dawley rats given 1.20% BHT for 1 week.
They found that BHT increased cholesteryl esters and
phospholipids while reducing triglyceride, nonesterified
lipid acids, and diglyceride. They also reported that BHT
increased the amount of phosphatidylethanolamine,
whereas
it
reduced
phosphatidylinositol
and
lysophosphatidylcholine amounts.
Sondergaard and Olsen (28) found that feeding rats
BHT at doses of 500 and 5000 ppm for different lengths
of time, up to 90 days resulted in an increase in thyroid
weight with both doses, and an increase in liver weight
for the 5000 ppm dose. Rhin et al. (29) stated that a single
injection of MCA produced genotoxic effects immediately,
within a 3-day period. In their study of MCA, they
observed increase trends in G:C → T:A and C:G → A:T
transversions in the DNA. In addition, following the
stimulation by BHT, MCA started mutations in Ki-ras and
p53 genes in various tissues.
It is obvious that MCA + BHT application increases
glycogen level in the liver but reduces it in the muscles
and testis, when compared to the control group (Figures
3, 4). In comparing MCA + BHT groups against the MCA
groups, glycogen levels were observed to increase in the
liver and muscles, and are at the lowest level in the testis
(Figure 4). These results suggest that BHT reduces the effect
of MCA in muscles while it does not affect levels in the
testis. Even though we did not evaluate hormone levels, we
think that MCA may directly, or indirectly, affect different
hormones. Likewise, Chance et al. (30) reported increases
and reductions in insulin and glucagon levels in F344 rats

BHT

2

MCA+BHT

1.5
1
0.5
0

Testis

Figure 4. Comparison of glycogen levels (%) in testis tissue
among control, BHT, and MCA + BHT groups.

given MCA. It was found that corticosterone and glucagon
levels were increased in tumorous rats. While an increase
was determined in glycogen levels of brain and skeletal
muscles, in spite of hypoglycemia and hypoinsulinemia, a
decrease was determined in glycogen level in the liver (31).
Thus, affected hormones will, although indirectly, lead to
changes in glycogen levels. The sensitivity of tumor tissues
to insulin explains why they collect glycogen.
When we examine the Table, we observe that glycogen
levels in the MCA + BHT group are lower than those in
the BHT group. When we compare MCA with the control
group, we see that glycogen levels in the MCA group are
lower than those in the other. In this case we mention
that glycogen levels in the groups including MCA will
be lowered. Thus, in a study by Besedovsky et al. (32), it
is observed that insulin levels are lowered in rats given
MCA. A decrease in the level of insulin gives rise to an
increase in the blood glucose level and, accordingly, to
the discharging of glycogen stores. In our research in the
groups administered MCA it is observed that there is
compliance between reducing glycogen level in tissues and
reduction of insulin levels in rats and mice given MCA, as
reported by Besedovsky et al. (32). The same researchers
declared that increases in corticosterone and prolactin
levels were observed after the inoculation of MCA in mice,
and a decrease in insulin, thyroxin, and sexual steroid
levels.
In conclusion, as cancer cells reproduce very quickly
and use high amounts of glycogen, glycogen levels in
tumoral tissues decrease from time to time. Future studies
should investigate enzyme activities with respect to
glycogen metabolism.
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